The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA3108808
Max Phase: Preclinical
Molecular Formula: C24H27N5O2S
Molecular Weight: 449.58
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: Cc1ccc(-c2nn3c(C)nnc3c3ccccc23)cc1S(=O)(=O)N(C)C1CCCCC1
Standard InChI: InChI=1S/C24H27N5O2S/c1-16-13-14-18(15-22(16)32(30,31)28(3)19-9-5-4-6-10-19)23-20-11-7-8-12-21(20)24-26-25-17(2)29(24)27-23/h7-8,11-15,19H,4-6,9-10H2,1-3H3
Standard InChI Key: UCNWYQMJWBSZFZ-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 449.58Molecular Weight (Monoisotopic): 449.1885AlogP: 4.51#Rotatable Bonds: 4Polar Surface Area: 80.46Molecular Species: NEUTRALHBA: 6HBD: 0#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 0CX Acidic pKa: CX Basic pKa: 1.47CX LogP: 4.20CX LogD: 4.20Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.46Np Likeness Score: -1.84
References 1. Fedorov O, Lingard H, Wells C, Monteiro OP, Picaud S, Keates T, Yapp C, Philpott M, Martin SJ, Felletar I, Marsden BD, Filippakopoulos P, Müller S, Knapp S, Brennan PE.. (2014) [1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains., 57 (2): [PMID:24313754 ] [10.1021/jm401568s ]